(Q37702155)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20201020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

The controversial relationship between NLRP3, alum, danger signals and the next-generation adjuvants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20201020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20201020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Alessandra Mortellaro

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20201020%20AND%20SRC:MED&resulttype=core&format=json

Paola Ricciardi-Castagnoli

19 January 2020

series ordinal

2

object named as

Paola Ricciardi-Castagnoli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20201020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

1 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20201020%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20201020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20201020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20201020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

638-642

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20201020%20AND%20SRC:MED&resulttype=core&format=json

Approaching the asymptote? Evolution and revolution in immunology

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

Mechanism of action of clinically approved adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Imject Alum is not aluminum hydroxide adjuvant or aluminum phosphate adjuvant

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Molecular identification of a danger signal that alerts the immune system to dying cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

(How) do aluminium adjuvants work?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

The inflammasomes: guardians of the body

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Gout-associated uric acid crystals activate the NALP3 inflammasome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Active caspase-1 is a regulator of unconventional protein secretion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Aluminium adjuvants--in retrospect and prospect

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Toll-like receptors control activation of adaptive immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Immunological and inflammatory functions of the interleukin-1 family

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

PEG-uricase in the management of treatment-resistant gout and hyperuricemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Extracellular signal-regulated kinase 1/extracellular signal-regulated kinase 2 mitogen-activated protein kinase signaling and activation of activator protein 1 and nuclear factor kappaB transcription factors play central roles in interleukin-8 expr

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Adjuvants--a balance between toxicity and adjuvanticity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021

The danger model: a renewed sense of self

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940039

7 January 2021